Vera Therapeutics, Inc.
VERA
$23.22
-$0.25-1.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 81.39% | -8.09% | -4.78% | 151.17% | 0.49% |
| Total Receivables | 88.93% | 1.89% | 20.17% | 218.55% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -26.20% | -3.45% | -24.14% | 22.77% | -12.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -19.13% | 163.17% | -24.47% | -74.61% | 16.39% |
| Total Current Assets | 78.84% | -7.76% | -5.19% | 142.04% | 0.23% |
|
|
|||||
| Total Current Assets | 78.84% | -7.76% | -5.19% | 142.04% | 0.23% |
| Net Property, Plant & Equipment | 1.00% | 105.81% | -17.07% | -17.36% | -13.49% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -6.43% | -69.57% | -2.75% | -1.87% | 2.55% |
| Total Assets | 77.90% | -7.23% | -5.26% | 138.89% | -0.04% |
|
|
|||||
| Total Accounts Payable | 66.56% | -1.33% | -10.46% | -53.15% | -9.61% |
| Total Accrued Expenses | -17.67% | 69.31% | 64.87% | -19.32% | -10.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -20.78% | -11.53% | -6.99% | -6.61% | -3.26% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -4.13% | 43.69% | 26.65% | -34.79% | -9.41% |
|
|
|||||
| Total Current Liabilities | -4.13% | 43.69% | 26.65% | -34.79% | -9.41% |
| Long-Term Debt | 0.43% | 0.41% | 0.39% | 0.38% | 99.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.89% | 464.40% | -50.49% | -34.12% | -28.90% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Liabilities | -1.23% | 14.52% | 5.48% | -10.89% | 42.28% |
|
|
|||||
| Common Stock & APIC | 47.06% | 0.90% | 1.20% | 68.37% | 0.81% |
| Retained Earnings | -10.39% | -12.56% | -9.99% | -9.18% | -9.05% |
| Treasury Stock & Other | -62.36% | 332.00% | -160.12% | -168.92% | 434.67% |
| Total Common Equity | 99.67% | -11.84% | -7.26% | 247.68% | -17.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 99.67% | -11.84% | -7.26% | 247.68% | -17.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 99.67% | -11.84% | -7.26% | 247.68% | -17.80% |
|
|
|||||